<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343229">
  <stage>Registered</stage>
  <submitdate>22/07/2011</submitdate>
  <approvaldate>22/07/2011</approvaldate>
  <actrnumber>ACTRN12611000772943</actrnumber>
  <trial_identification>
    <studytitle>Comparison between intraarticular dexmedetomidine and morphine for postoperative analgesia after arthroscopic meniscal surgery</studytitle>
    <scientifictitle>Comparison between intraarticular dexmedetomidine and morphine for postoperative analgesia after arthroscopic meniscal surgery</scientifictitle>
    <utrn>U1111-1123-1121</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Postoperative analgesia</healthcondition>
    <healthcondition>Arthroscopy</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Arm 1: Intra-articular dexmedetomidine 1 mcg/kg (in 20 ml saline) before wound closure once
Arm 2: Intra-articular morphine 30 mcg/kg (in 20 ml saline) before wound closure once</interventions>
    <comparator>Arm 3: Intra-articular saline 20 ml before wound closure once</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Visual analogue scale (VAS) score (0-10) at rest</outcome>
      <timepoint>Before induction of anesthesia, on arrival to recovery room, and at 1, 2, 3, 4, 6, 8, 12, 18, 24, 30, 36, 42, and 48 hours after surgery</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Visual analogue scale (VAS) score (0-10) on movement</outcome>
      <timepoint>Before induction of anesthesia, on arrival to recovery room, and at 1, 2, 3, 4, 6, 8, 12, 18, 24, 30, 36, 42, and 48 hours after surgery</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Observers Assessment of Alertness and Sedation (OAA/S) score</outcome>
      <timepoint>Before induction of anesthesia, on arrival to recovery room, and at 1, 2, 3, 4, 6, 8, 12, 18, 24, 30, 36, 42, and 48 hours after surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Time to first analgesia request postoperatively (minutes)</outcome>
      <timepoint>Up to 48 hours postoperatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Total amount of tramadol administered postoperatively</outcome>
      <timepoint>Up to 48 hours postoperatively</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>- American Society of Anesthesiologists physical class I or II
- Arthroscopic meniscal surgery under general anaesthesia
- Elective surgery</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>- Regional anaesthesia
- History of opioids or sedative agents use on regular basis for more than a week prior to surgery
- renal impairment (serum creatinine &gt; 200 mcg/ml)</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Patients are screened for eligibility by a reaserach assistant. After informed consent is obtained, study medication is prepared in pharmacy. Study group allocation is done using sealed serially numbered opaque envelopes based on the randomization schedule.</concealment>
    <sequence>Randomization is performed using a computer-generated randomization schedule</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3 / Phase 4</phase>
    <anticipatedstartdate>9/04/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>45</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Saudi Arabia</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>King Abdulaziz University</primarysponsorname>
    <primarysponsoraddress>P.O. Box 80215
Jeddah 21589</primarysponsoraddress>
    <primarysponsorcountry>Saudi Arabia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Department of Anesthesia and Critical Care, King Abdulaziz University</fundingname>
      <fundingaddress>P.O. Box 80215
Jeddah 21589</fundingaddress>
      <fundingcountry>Saudi Arabia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This randomized double-blind study was designed to determine the analgesic effects of intra-articular dexmedetomidine and to compare it with those of morphine in patients undergoing arthroscopic knee surgery.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Research and Ethics Committee</ethicname>
      <ethicaddress>Department of Anesthesia and Critical Care
P.O. Box 80215
Jeddah 21589</ethicaddress>
      <ethicapprovaldate>29/03/2011</ethicapprovaldate>
      <hrec>ANE08-11</hrec>
      <ethicsubmitdate />
      <ethiccountry>Saudi Arabia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr. Walid Almarakbi</name>
      <address>Department of Anesthesia and Critical Care
King Abdulaziz University Hospital
P.O. Box 80215
Jeddah 21589</address>
      <phone>966-2-6408335</phone>
      <fax />
      <email>waleedelmarakby@yahoo.com</email>
      <country>Saudi Arabia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr. Walid Almarakbi</name>
      <address>Department of Anesthesia and Critical Care
King Abdulaziz University Hospital
P.O. Box 80215
Jeddah 21589</address>
      <phone>96626408335</phone>
      <fax />
      <email>waleedelmarakby@yahoo.com</email>
      <country>Saudi Arabia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Prof. Jamal Alhashemi</name>
      <address>Department of Anesthesia and Critical Care
King Abdulaziz University Hospital
P.O. Box 80215
Jeddah 21589</address>
      <phone />
      <fax />
      <email>jalhashemi@kau.edu.sa</email>
      <country>Saudi Arabia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>